பீட்டர் வெஸ்ட்லேக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பீட்டர் வெஸ்ட்லேக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பீட்டர் வெஸ்ட்லேக் Today - Breaking & Trending Today

ProciseDx Raises $13M in Convertible Note Financing

Participants included existing major shareholders (Nestlé Heath Science, Biosynex SA) management and new investors.
The company intends to use the funds to move forward with FDA submissions for the platform and to expand the test menu for gastroenterologists.
Led by CEO and CSO Dr. Larry Mimms and President and CFO Peter Westlake, ProciseDx provides a broad portfolio of rapid diagnostic tests for the physician’s office, which use a finger prick blood sample or a stool sample and have a turn-around time of 2-5 minutes. ProciseDx has obtained CE Mark on its instrument and on four gastroenterology (GI) assays which were launched in Q3 2020. The company has established distribution relationships in more than 15 countries in Europe, Middle East and Africa (EMEA) and expects to continue its market expansion for the rest of 2021. Already over 100 instruments have been shipped to EMEA and further growth is expected in the second half of 2021. The company expects revenues ....

San Diego , United States , Peter Westlake , Larry Mimms , Heath Science , Middle East , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் வெஸ்ட்லேக் , லாரி மிம்ம்ஸ் , ஹீத் அறிவியல் , நடுத்தர கிழக்கு ,

ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth

ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Illkirch Graffenstaden , Peter Westlake , Remicade Procise , Larry Mimms , Colitis Organization , Prnewswire Procisedx Inc , Health Science , Procisedx Inc , Health Science Nhsc , Heath Science , Procisedx Point Of Care , Middle East , C Reactive Protein , European Crohn , Rapid Diagnostic Tests , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , பீட்டர் வெஸ்ட்லேக் , லாரி மிம்ம்ஸ் , பெருங்குடல் அழற்சி ஆர்கநைஸேஶந் , ஆரோக்கியம் அறிவியல் , ஹீத் அறிவியல் , நடுத்தர கிழக்கு , ஐரோப்பிய குரோன் ,

ProciseDx Achieves CE Mark for Fecal Calprotectin Point of Care Testing

ProciseDx Achieves CE Mark for Fecal Calprotectin Point of Care Testing
News provided by
Share this article
Share this article
SAN DIEGO, Feb. 23, 2021 /PRNewswire/ ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system. Offering a point of care test for fecal calprotectin will help many physicians expedite their diagnosis of Crohn s Disease or Ulcerative Colitis, as well as other digestive conditions. The test can be completed in under 5 minutes with the ProciseDx platform.
The ProciseDx instrument is about the size of a shoe box and can provide diagnostics results in as little as 2 minutes from a finger prick drop of blood. Procise FCP uses stool from our patient home use Stool Collection Device. ....

United States , San Diego , Noord Holland , Peter Westlake , Geert Dhaens , Procisedx Inc , Professor Gastroenterology At Amsterdam Medical Center , International Jacques Cavadenti , Fecal Calprotectin , Ulcerative Colitis , Geertd Haens , Professor Gastroenterology , Amsterdam Medical Center , Fecal Calpro , Therapeutic Drug Monitoring , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , நூற்த் ஹாலண்ட் , பீட்டர் வெஸ்ட்லேக் , ப்ரொஃபெஸர் இரைப்பை குடல் இல் ஆம்ஸ்டர்டாம் மருத்துவ மையம் , ப்ரொஃபெஸர் இரைப்பை குடல் , ஆம்ஸ்டர்டாம் மருத்துவ மையம் , மலம் கல்ப்ரோ , சிகிச்சை மருந்து கண்காணிப்பு ,